Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib

Noppadon KongsuphonMaturos SoukavanitchNoramon TeeraaumpornpuntJitprapa KonmunTouch AtivitavasNuttapong NgamphaiboonFaculty of Medicine, Ramathibodi Hospital, Mahidol University2020-01-272020-01-272019-09-15Journal of Gastrointestinal Cancer. Vol.50, No.3 (2019), 601-60319416636194166282-s2.0-85041627744https://repository.li.mahidol.ac.th/handle/123456789/51413Mahidol UniversityMedicineMulti-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and RegorafenibArticleSCOPUS10.1007/s12029-018-0067-6